Furthermore, C5 was characterized by 18q and chromosome 3 gains and mutations of CD79B, MYD88, and Pim-1, overlapping with the transcriptomic profile of ABC-DLBCL. The gene discussed is CD79B; the disease is diffuse large B-cell lymphoma.